|
CIR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.91300008956352E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.05299999725506E-08 |
| Normal-vs-Stage2 |
5.96820004528098E-09 |
| Normal-vs-Stage3 |
3.38960000068056E-08 |
| Normal-vs-Stage4 |
3.11490000015624E-07 |
| Stage1-vs-Stage2 |
1.410460E-02 |
| Stage1-vs-Stage3 |
8.965600E-02 |
| Stage1-vs-Stage4 |
2.323800E-01 |
| Stage2-vs-Stage3 |
3.489400E-01 |
| Stage2-vs-Stage4 |
3.238800E-01 |
| Stage3-vs-Stage4 |
9.057800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.66639957177983E-10 |
| Normal-vs-AfricanAmerican |
4.57269999998289E-06 |
| Normal-vs-Asian |
4.848100E-04 |
| Caucasian-vs-AfricanAmerican |
4.734600E-01 |
| Caucasian-vs-Asian |
1.033770E-01 |
| AfricanAmerican-vs-Asian |
8.686300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.13299999949091E-07 |
| Normal-vs-Female |
7.22799597951962E-11 |
| Male-vs-Female |
3.079600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.19899999928563E-08 |
| Normal-vs-Age(41-60Yrs) |
2.95530000471445E-08 |
| Normal-vs-Age(61-80Yrs) |
9.41659972220066E-10 |
| Normal-vs-Age(81-100Yrs) |
1.209970E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.956800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.555800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.699430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.572400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.961770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.093400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.029820E-01 |
| Classical-VS-Follicular |
1.598200E-02 |
| Classical-VS-Other |
5.490400E-01 |
| Classical-VS-Normal |
6.04809999860123E-08 |
| Tall-VS-Follicular |
9.158600E-01 |
| Tall-VS-Other |
2.182600E-01 |
| Tall-VS-Normal |
2.03570000001374E-06 |
| Follicular-VS-Other |
2.085800E-01 |
| Follicular-VS-Normal |
1.13239999599557E-08 |
| Other-VS-Normal |
1.330450E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.29669949725064E-10 |
| Normal-vs-N1 |
1.67249999999397E-05 |
| N0-vs-N1 |
3.035400E-01 |
|
|
